FUNDING ROUND open on march 2023

all the information here

We aim to finance Phase III clinical trials for brain tumor treatment. Previous funding round closed for a total of 3.1 million euros

For more information about this investment opportunity

email inversores@laminarpharma.com.

You can also find the information about the last

Crowdfunding for Laminar Pharma at Capital Cell

finished successfully in July 2022.

Company News

Scientific publications